Byrne Asset Management »

SPDR S&P Biotech shares owned by Byrne Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Byrne Asset Management from 13F filings

Historical chart of Byrne Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Byrne Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $658k 5.4k 121.93

More positions owned by Byrne Asset Management

Google
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Visa (V)
Rtx Corp
Advanced Micro Devices (AMD)
Applied Materials (AMAT)
Toll Brothers (TOL)
KKR & Co
International Business Machines (IBM)

View all positions for Byrne Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech